Zidovudine induces S-phase arrest and cell cycle gene expression changes in human cells
Open Access
- 1 March 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Mutagenesis
- Vol. 20 (2) , 139-146
- https://doi.org/10.1093/mutage/gei019
Abstract
Antiretroviral therapy for the human immunodeficiency virus-1 (HIV-1) typically includes two nucleoside reverse transcriptase inhibitors (NRTIs). 3′-Azido-3′-deoxythymidine (AZT, Zidovudine) plus 2′-deoxy-3′-thiacytidine (3TC, Lamivudine) is a combination that is used frequently. The NRTIs are mutagenic nucleoside analogs that become incorporated into DNA and terminate replication. We therefore hypothesized that exposure to this class of drug may alter cell cycle parameters. We used flow cytometry to examine the cell cycle in human epithelioid carcinoma (HeLa) cells exposed to AZT and 3TC alone, as well as a series of AZT/3TC dose combinations: (A) 125.0 µM AZT/12.5 µM 3TC; (B) 250.0 µM AZT/25.0 µM 3TC; and (C) 500 µM AZT/50 µM 3TC. At 24 h, at all doses, there was a good cell viability (≥68%), and incorporation of AZT into nuclear DNA. Using flow cytometry, a dose-related increase in the percentage of cells in S phase, from 9.5% with no drug, to 36.0% with dose C, was observed in cells exposed for 24 h (P = 0.001, ANOVA). A concomitant decrease in the percentage of cells in G1 phase, from 82.6% with no drug to 58.5% with dose C, was observed in cells exposed for 24 h (P = 0.017, ANOVA). A similar S phase arrest was seen in cells exposed to 125, 250 and 500 µM AZT alone, but there was no S phase alteration with 50 µM 3TC alone, suggesting that AZT is responsible for the accumulation of cells in S phase. To elucidate the accumulation of cells in S phase and explore the cell cycle gene expression changes induced by AZT and 3TC, we used c-DNA microarray, Cell Cycle Super Array and real-time PCR. There was a strong upregulation of the DNA damage-inducible transcript 3 (DDIT3 or GADD153) in NRTI-exposed cells. In addition, AZT induced an upregulation of cyclin D1 accompanied by a downregulation of the cyclin D1-associated inhibitors P18 and P57, and the G1-S check point gene P21, the net effect of which would be to foster a cell progression into S phase. Cyclin A2 was down-regulated in cells exposed to AZT, suggesting a block in S–G2–M progression that would also be consistent with the accumulation of cells in S phase. Overall, the study demonstrates that AZT, but not 3TC, causes an arrest of cells in S phase with a consistent alteration in the expression of several cell cycle genes.Keywords
This publication has 23 references indexed in Scilit:
- Perinatal genotoxicity and carcinogenicity of anti-retroviral nucleoside analog drugsToxicology and Applied Pharmacology, 2004
- CHOP Transcription Factor Phosphorylation by Casein Kinase 2 Inhibits Transcriptional ActivationJournal of Biological Chemistry, 2003
- Cell cycle progression without cyclin E/CDK2Cancer Cell, 2003
- Bared essentials of CDK2 and cyclin ENature Genetics, 2003
- Cell Cycle Control and Cell Division: Implications for Chemically Induced Carcinogenesis The frontispiece background image of fluorescent asynchronous human cervical carcinoma HeLa S3 cells was kindly provided by Jon Hoyt and Randall W. King, Harvard Medical School, Boston. A glossary can be found at the end of the text.ChemBioChem, 2002
- Stress-Inducible Transcription Factor CHOP/gadd153 Induces Apoptosis in Mammalian Cells via p38 Kinase-Dependent and -Independent MechanismsExperimental Cell Research, 2001
- Protection by Protein A of Apoptotic Cell Death Caused by Anti-AIDS Drug ZidovudineBiochemical and Biophysical Research Communications, 1999
- CYCLINS AND CELL CYCLE CHECKPOINTSAnnual Review of Pharmacology and Toxicology, 1999
- Requirement for p53 and p21 to Sustain G 2 Arrest After DNA DamageScience, 1998
- Recombinant human interferon beta ser protects against zidovudine-induced genetic damage in AIDS patientsAntiviral Research, 1991